Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30

$1.71−0.29 (-14.50%)

Close on Nov 13, 2026Market cap $101.29MP/E –Yield –

Adagene EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Adagene has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADAG.

Revenue growth7332.8% · median -63.3%

Operating margin-279.5% · median -1157.3%

Net margin-229.6% · median -881.0%

Advertisement
300 × 250

See a number that looks wrong?